Thermo Fisher Scientific, The World Leader In Serving Science, Today Announced The Launch Of The Taqpath Enteric Bacterial Select Panel, A Ce-Ivd Marked Panel Designed To Detect Common Gastrointestinal (Gi) Bacteria And Help Enable Clinicians To Identify The Root Cause Of An Infection And Administer The Most Appropriate Treatment To Their Patients More Quickly. The Panel Was Validated And Registered Under Ivdd In May 2022.The New Test Leverages Polymerase Chain Reaction (Pcr) Technology To Analyze Stool Samples For A Range Of Common Gi Bacteria, Including Salmonella Spp.; Shigella Spp./Enteroinvasive E. Coli (Eiec); Campylobacter Jejuni, Campylobacter Coli, And Campylobacter Upsaliensis. It Is Able To Reliably Return Results In About Two Hours With More Than 98 Percent Sensitivity And Specificity. In Comparison, Culturing Samples In A Laboratory Can Take Up To Two Weeks To Deliver Results.
